$56.50
-0.58 (-1.02%)
Amgen, Inc. (AMGN)
CAPS Rating:
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

RSS Headlines
Fool UK